Seminoma laboratory findings: Difference between revisions

Jump to navigation Jump to search
 
(25 intermediate revisions by 3 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
Laboratory findings consistent with the diagnosis of seminoma include [[Complete blood count]] ([[Complete blood count|CBC]]), [[white blood cells]], [[Red blood cell|red blood cells]], and [[platelets]]. Kidney function tests is used before and after [[orchiectomy]]. [[tumor marker|Serum tumor marker]] tests are generally used to check the response to cancer treatment. The following [[Tumor marker|tumor markers]] may be measured for [[testicular]] seminoma.Laboratory findings consistent with the diagnosis of seminoma include abnormal [[serum]] [[tumor marker]] levels ([[LDH]], [[HCG]]). Some [[Patient|patients]] with seminoma may have elevated concentration of [[Lactate dehydrogenase|LDH]]. Among some [[Patient|patients]] with seminoma may have elevated concentration of [[HCG|human chorionic gonadotropin (hCG)]]. [[Blood test|Blood tests]] may detect the presence of [[placental alkaline phosphatase]] (PLAP) among 50% of [[Patient|patients]] with seminoma.


==Laboratory Findings==
==Laboratory Findings==
===Complete Blood Count===
===Complete Blood Count===
[[Complete blood count]] (CBC) measures the number and quality of white blood cells, red blood cells, and platelets. A CBC is done to check the general health of the patient.<ref name=Diagnosisoftesticularcancer1>Diagnosis of testicular cancer. Canadian cancer society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/testicular/diagnosis/?region=on. Accessed on March 2, 2016</ref>
[[Complete blood count]] ([[Complete blood count|CBC]]) measures the number and quality of [[white blood cells]], [[Red blood cell|red blood cells]], and [[platelets]].<ref> American cancer society,https://www.cancer.org/cancer/testicular-cancer/detection-diagnosis-staging/how-diagnosed.html Accessed on May 7, 2019</ref>


===Blood Chemistry Tests===
===Blood Chemistry Tests===
*Blood chemistry tests that are used to diagnose testicular seminoma include the following:
*[[Blood]] [[chemistry]] tests that are used to [[Diagnosis|diagnose]] [[testicular]] seminoma include the following:
:*[[LFT|Liver function tests]], or a liver panel, may be done to find out what is causing abdominal pain or discomfort. High levels of certain substances in the blood may mean that seminoma has spread to the liver.
*
*[[LFT|Liver function tests]]:
**High levels of certain substances in the [[blood]] may mean that seminoma has spread to the [[liver]].
*[[Kidney]] function tests:
**It is used before and after [[orchiectomy]].


Kidney function tests are used to check how well the kidneys are working. They are often done before and after surgery to remove one or both testicles (called orchiectomy).
===Tumor Marker Tests===
 
*[[tumor marker|Serum tumor marker]] tests are generally used to check the response to cancer treatment. The following tumor markers may be measured for testicular seminoma.<ref name="pmid27150447">{{cite journal |vauthors=Iwatsuki S, Naiki T, Kawai N, Etani T, Iida K, Ando R, Nagai T, Okada A, Tozawa K, Sugiyama Y, Yasui T |title=Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report |journal=J Med Case Rep |volume=10 |issue=1 |pages=114 |date=May 2016 |pmid=27150447 |pmc=4858825 |doi=10.1186/s13256-016-0906-7 |url=}}</ref><ref name="pmid24198649">{{cite journal |vauthors=Milose JC, Filson CP, Weizer AZ, Hafez KS, Montgomery JS |title=Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance |journal=Open Access J Urol |volume=4 |issue= |pages=1–8 |date=December 2011 |pmid=24198649 |pmc=3818947 |doi=10.2147/OAJU.S15063 |url=}}</ref><ref name="pmid24502963">{{cite journal |vauthors=Lempiäinen A, Sankila A, Hotakainen K, Haglund C, Blomqvist C, Stenman UH |title=Expression of human chorionic gonadotropin in testicular germ cell tumors |journal=Urol. Oncol. |volume=32 |issue=5 |pages=727–34 |date=July 2014 |pmid=24502963 |doi=10.1016/j.urolonc.2013.11.007 |url=}}</ref><ref name="pmid8653285">{{cite journal |vauthors=Koshida K, Uchibayashi T, Yamamoto H, Hirano K |title=Significance of placental alkaline phosphatase (PLAP) in the monitoring of patients with seminoma |journal=Br J Urol |volume=77 |issue=1 |pages=138–42 |date=January 1996 |pmid=8653285 |doi= |url=}}</ref>
Doctors often order blood chemistry tests in preparation for testicular cancer treatments. These levels help create a starting point used to compare future levels. This is known as a baseline.
:*Classical or pure seminoma do not cause an elevated [[AFP|serum alpha fetoprotein]].
 
:*[[LDH|Lactate dehydrogenase (LDH)]] may be the only marker that is elevated in some seminomas. The degree of [[elevation]] in the [[serum]] [[LDH]] has [[prognostic]] value in advanced seminoma. High [[LDH]] levels can indicate that the [[tumor]] is large, there is a large amount of [[cancer]] in the [[body]], or the [[cancer]] is growing quickly. High levels can also mean that a man has advanced seminoma. [[Lactate dehydrogenase|LDH]] may also be high with some non-cancerous conditions.
Find out more about blood chemistry tests.
:*[[HCG|Human chorionic gonadotropin (hCG)]] may be elevated in some cases, but this correlates more to the presence of trophoblast cells within the [[tumor]]. [[HCG]] can also be high, if the man has liver [[disease]].
 
:*[[Blood test|Blood tests]] may detect the presence of [[placental alkaline phosphatase]] (PLAP) in 50% of cases. However, PLAP cannot usefully stand alone as a marker for seminoma and contributes little to follow-up, due to its rise with [[smoking]].
Back to top
 
Tumour marker tests
 
Tumour markers are substances in the blood that may mean testicular cancer is present. Tumour marker tests are generally used to check your response to cancer treatment. They can also be used to diagnose testicular cancer.
 
These tumour markers may be measured for testicular cancer:
 
Alpha-fetoprotein (AFP) levels are often higher when a type of testicular cancer called non-seminoma germ cell tumour is present. AFP is never high for seminomas, which is another type of testicular cancer.
 
Human chorionic gonadotropin (HCG) levels can be higher in men with a seminoma or non-seminoma. HCG can also be high if the man has liver disease.
 
Lactase dehydrogenase (LDH) levels may be higher in men with a seminoma or non-seminoma. High LDH levels can indicate that the tumour is large, there is a large amount of cancer in the body, or the cancer is growing quickly. High levels can also mean that a man has advanced testicular cancer. LDH may also be high with some non-cancerous conditions.
 
 
 
Read more: http://www.cancer.ca/en/cancer-information/cancer-type/testicular/diagnosis/?region=on#ixzz41mVSCehF


==References==
==References==
Line 46: Line 34:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Urology]]

Latest revision as of 18:03, 7 May 2019

Seminoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Seminoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

TNM
Stage Grouping

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Treatment - Stage I
Treatment - Stage II
Treatment - Stage III
Treatment - Recurrent

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Seminoma laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Seminoma laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Seminoma laboratory findings

CDC on Seminoma laboratory findings

Seminoma laboratory findings in the news

Blogs on Seminoma laboratory findings

Directions to Hospitals Treating Seminoma

Risk calculators and risk factors for Seminoma laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Laboratory findings consistent with the diagnosis of seminoma include Complete blood count (CBC), white blood cells, red blood cells, and platelets. Kidney function tests is used before and after orchiectomy. Serum tumor marker tests are generally used to check the response to cancer treatment. The following tumor markers may be measured for testicular seminoma.Laboratory findings consistent with the diagnosis of seminoma include abnormal serum tumor marker levels (LDH, HCG). Some patients with seminoma may have elevated concentration of LDH. Among some patients with seminoma may have elevated concentration of human chorionic gonadotropin (hCG). Blood tests may detect the presence of placental alkaline phosphatase (PLAP) among 50% of patients with seminoma.

Laboratory Findings

Complete Blood Count

Complete blood count (CBC) measures the number and quality of white blood cells, red blood cells, and platelets.[1]

Blood Chemistry Tests

Tumor Marker Tests

  • Serum tumor marker tests are generally used to check the response to cancer treatment. The following tumor markers may be measured for testicular seminoma.[2][3][4][5]

References

  1. American cancer society,https://www.cancer.org/cancer/testicular-cancer/detection-diagnosis-staging/how-diagnosed.html Accessed on May 7, 2019
  2. Iwatsuki S, Naiki T, Kawai N, Etani T, Iida K, Ando R, Nagai T, Okada A, Tozawa K, Sugiyama Y, Yasui T (May 2016). "Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report". J Med Case Rep. 10 (1): 114. doi:10.1186/s13256-016-0906-7. PMC 4858825. PMID 27150447.
  3. Milose JC, Filson CP, Weizer AZ, Hafez KS, Montgomery JS (December 2011). "Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance". Open Access J Urol. 4: 1–8. doi:10.2147/OAJU.S15063. PMC 3818947. PMID 24198649.
  4. Lempiäinen A, Sankila A, Hotakainen K, Haglund C, Blomqvist C, Stenman UH (July 2014). "Expression of human chorionic gonadotropin in testicular germ cell tumors". Urol. Oncol. 32 (5): 727–34. doi:10.1016/j.urolonc.2013.11.007. PMID 24502963.
  5. Koshida K, Uchibayashi T, Yamamoto H, Hirano K (January 1996). "Significance of placental alkaline phosphatase (PLAP) in the monitoring of patients with seminoma". Br J Urol. 77 (1): 138–42. PMID 8653285.

Template:WH Template:WS